bupropion has been researched along with Chronic Kidney Diseases in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bupropion was used as a probe substrate for hepatic CYP2B function using rat liver microsomes." | 1.51 | The effect of chronic kidney disease on CYP2B expression and activity in male Wistar rats. ( Kucey, AS; RaoPeters, AAE; Tieu, A; Tonial, NC; Urquhart, BL; Velenosi, TJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kucey, AS | 1 |
| Velenosi, TJ | 1 |
| Tonial, NC | 1 |
| Tieu, A | 1 |
| RaoPeters, AAE | 1 |
| Urquhart, BL | 1 |
1 other study available for bupropion and Chronic Kidney Diseases
| Article | Year |
|---|---|
The effect of chronic kidney disease on CYP2B expression and activity in male Wistar rats.
Topics: Adenine; Animals; Aryl Hydrocarbon Hydroxylases; Bupropion; Cytochrome P-450 CYP2B1; Disease Models, | 2019 |